Status:
UNKNOWN
The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Refractory Diabetic Macular Edema
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
after advent of RD photoreceptor degeneration Occurred. This process appears as a incredible and progressive event that will not stop till reattachment of RPE and neurosensory retina happened . Proce...
Eligibility Criteria
Inclusion
- Patient with refractory diabetic macular edema at least one month after third injection
Exclusion
- previous vitreoretinal surgery previous glaucoma surgery glaucomatous patient open heart surgery active proliferative diabetic retinopathy one eye patients vitreous hemorrhage
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2019
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT03821168
Start Date
March 1 2019
End Date
October 1 2019
Last Update
February 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Research Center
Tehran, Iran